VALACICLOVIR SCP valaciclovir 1000mg (as hydrochloride) tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

valaciclovir hydrochloride, Quantity: 1112.48 mg (Equivalent: valaciclovir, Qty 1000 mg)

Verfügbar ab:

Southern XP IP Pty Ltd

INN (Internationale Bezeichnung):

valaciclovir hydrochloride

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: hypromellose; maize starch; magnesium stearate; croscarmellose sodium; macrogol 400; titanium dioxide; lactose monohydrate; polysorbate 80; povidone

Verabreichungsweg:

Oral

Einheiten im Paket:

4 Tablet

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash; treatment of ophthalmic zoster; treatment of recurrent herpes labialis (cold sores); treatment of clinical episodes of genital herpes simplex infections; prevention of recurrent genital herpes; reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. In addition to therapy with valaciclovir, it is recommended that patients use safer sex practices (see Precautions); prophylaxis of cytomegalovirus (CMV) infection and disease following solid organ transplantation in patients at risk of CMV disease.

Produktbesonderheiten:

Visual Identification: Creamy oblong film coated tablets. the 1000mg tablets have a breaking notch; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2010-12-10